Absence of influence of gender and <it>BMPR2 </it>mutation type on clinical phenotypes of pulmonary arterial hypertension
<p>Abstract</p> <p>Background</p> <p>Previous studies indicate that patients with pulmonary arterial hypertension (PAH) carrying a mutation in the bone morphogenetic protein receptor type 2 (<it>BMPR2</it>) gene, develop the disease 10 years earlier than non...
Main Authors: | Yaici Azzedine, Eyries Mélanie, Montani David, Girerd Barbara, Sztrymf Benjamin, Coulet Florence, Sitbon Olivier, Simonneau Gérald, Soubrier Florent, Humbert Marc |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/11/1/73 |
Similar Items
-
Review: Therapeutic advances in pulmonary arterial hypertension
by: K. Boutet, et al.
Published: (2008-08-01) -
A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
by: Delphine Bourlier, et al.
Published: (2016-03-01) -
The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension
by: Alexandru Steriade, et al.
Published: (2014-06-01) -
Drug-induced pulmonary arterial hypertension: a recent outbreak
by: Gérald Simonneau, et al.
Published: (2013-09-01) -
Heritable pulmonary hypertension: from bench to bedside
by: Barbara Girerd, et al.
Published: (2017-09-01)